RecruitingNCT06651112
Brain energy changes after a first episode of psychosis and antipsychotic treatment
About this title
Read the official source — NCT06651112Observational studyAges 18–35CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 35 years.
What will I do during this study?
You undergo brain imaging and assessments of symptoms and thinking abilities while beginning an antipsychotic prescribed as part of usual care. The research also examines metabolic and inflammation-related measures.
- Listed locations
- SherbrookeSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 18
- Sponsor
- Université de Sherbrooke
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT06651112
- Official title
Show the full official title
Impacts of Psychosis and Antipsychotics on Cerebral Energy Metabolism: the ATP Project (Antipsychotic-TEP-Psychosis)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Sherbrooke
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Université de Sherbrooke, a university.
Does this study involve medication?
Yes. The study involves medication, including Antipsychotic drugs.
Who can participate?
Listed age limits: 18 years to 35 years.
Is this study still recruiting?
The registry lists this study as recruiting.
